|Bid price||1,269.00||Open price||1,258.00|
|Ask price||1,274.00||Prev close||1,269.00|
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Register now for FREE Dechra Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009633180|
|Activites||Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.||Index||FTSE 250|
|Latest Share Price (p)||1,269.00||Net Gearing (%)||17.70|
|Market Capitalisation (£m)||1,162.06||Gross Gearing (%)||33.42|
|Shares in issue (m)||92.71||Debt Ratio||21.58|
|P/E Ratio||56.62||Debt-to-Equity Ratio||0.55|
|Total dividends per share (p)||16.94||Assets / Equity Ratio||1.50|
|Dividend Yield (%)||1.39||Price to book value||5.97|
|Dividend cover (x)||1.25||ROCE (%)||10.41|
|Earning per share (p)||22.14||EPS Growth (%)||-67.23|
|52 week high / low||1,273.00 / 811.00||DPS Growth (%)||10.00|
|Dec.Date||Type||Director||Pos||No. of Shares|
A stronger pound versus the euro saw the internationally focused FTSE 100 fall flat but was a boon for the domestically biased FTSE 250, up by 0.4% to 16,780.09. Lucky Strike owner British American Tobacco (BATS) retreated 1.7% to 4,836.5p, contributing to negative momentum in the FTSE 100....
Numis today reaffirms its add investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and set its price target at 1320p. Story provided by StockMarketWire.com
UK companies continued to bloom as the FTSE 250 advanced towards the 17,000 mark after Theresa May was announced as the new Prime Minister from 13 July. The FTSE 100 slid 0.08% to 6,677.18, while the FTSE 250 climbed 0.8% to 16,836.99. Investors were comforted by the new premier as May is seen...
Register now for FREE Dechra Pharmaceuticals company news
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...
Register now for FREE Dechra Pharmaceuticals share price discussions